Cancer Research Career Enhancement (CRCE) and Related Activities at the Georgetown Lombardi Comprehensive Cancer Center (LCCC) are designed to leverage and enhance the outstanding array of educational and career advancement activities available within LCCC, Georgetown University Medical Center (GUMC), Georgetown University (GU), the MedStar Georgetown Cancer Institute (MGCI; the oncology clinical service line) and John Theurer Cancer Center (JTCC). Core educational programs include the Accreditation Council for Graduate Medical Education (ACGME)-accredited Hematology and Oncology Fellowship Programs at MedStar Georgetown University Hospital (MGUH) and MedStar Washington Hospital Center (MWHC) (20 and 14 graduates in the past five years, respectively), the T32-supported Interdisciplinary Program in Tumor Biology (TBIO) doctoral and postdoctoral fellowship training program (33 students, 26 fellows) and the master?s programs in tumor biology (56 students) and biostatistics (147 students). Other training programs among the 32 ACGME- accredited programs at GUMC with a considerable focus on cancer research include residency and/or fellowship programs in radiation oncology, urology, surgery, pathology, cytopathology, internal medicine and radiology. Training in basic and clinical cancer research is a major component of these programs. In developing the next generation of cancer researchers, LCCC runs and participates in an array of education programs for high school and undergraduate students that have provided opportunities for hands-on experience with cancer research for more than 200 students in the past five years. These programs include career development and mentoring components designed to encourage the candidates to consider a career in cancer research and help foster and advance that career. Ongoing CRCE activities are expanding to support the overall goal of encouraging and supporting clinicians and scientists of all backgrounds to achieve success in cancer-research directed careers. We will achieve this goal through the following specific aims: 1) Develop and support innovative research programs and opportunities for high school and undergraduate students to provide rewarding, transformative experiences for students from all backgrounds within the catchment area to encourage them to explore careers in cancer research; 2) Provide an enhanced transdisciplinary training environment for residents, graduate students, postdoctoral fellows and clinical fellows to facilitate translational cancer research and career development; 3) Provide the most effective mentoring and career development structure possible for junior basic and clinical cancer research faculty; and 4) Conduct ongoing metric-based assessment of existing and developing education, training, career development and mentoring activities to optimize the delivery of the most effective programs possible.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA051008-27
Application #
9924505
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
27
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications